These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 31678521)

  • 1. Nasal route for vaccine and drug delivery: Features and current opportunities.
    Lobaina Mato Y
    Int J Pharm; 2019 Dec; 572():118813. PubMed ID: 31678521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal formulations: promising strategy to deliver vaccines.
    Riese P; Sakthivel P; Trittel S; Guzmán CA
    Expert Opin Drug Deliv; 2014 Oct; 11(10):1619-34. PubMed ID: 24962722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dry powder nasal vaccines as an alternative to needle-based delivery.
    Hickey AJ; Garmise RJ
    Crit Rev Ther Drug Carrier Syst; 2009; 26(1):1-27. PubMed ID: 19496746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies to facilitate or block nose-to-brain drug delivery.
    Martins PP; Smyth HDC; Cui Z
    Int J Pharm; 2019 Oct; 570():118635. PubMed ID: 31445062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal Nanoparticulate Systems as Alternative Route of Drug Delivery.
    Alshweiat A; Ambrus R; Csoka I
    Curr Med Chem; 2019; 26(35):6459-6492. PubMed ID: 31453778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrogel nanoparticles and nanocomposites for nasal drug/vaccine delivery.
    Salatin S; Barar J; Barzegar-Jalali M; Adibkia K; Milani MA; Jelvehgari M
    Arch Pharm Res; 2016 Sep; 39(9):1181-92. PubMed ID: 27352214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal delivery of high molecular weight drugs.
    Ozsoy Y; Gungor S; Cevher E
    Molecules; 2009 Sep; 14(9):3754-79. PubMed ID: 19783956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal Drug Delivery: A Non-Invasive Approach for the Better Delivery of Neurotherapeutics.
    Kumar H; Mishra G; Sharma AK; Gothwal A; Kesharwani P; Gupta U
    Pharm Nanotechnol; 2017; 5(3):203-214. PubMed ID: 28521670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent trends in drug delivery systems: intranasal drug delivery.
    Agarwal V; Mishra B
    Indian J Exp Biol; 1999 Jan; 37(1):6-16. PubMed ID: 10355359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticles for nasal vaccination.
    Csaba N; Garcia-Fuentes M; Alonso MJ
    Adv Drug Deliv Rev; 2009 Feb; 61(2):140-57. PubMed ID: 19121350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal formulations for drug administration and characterization of nasal preparations in drug delivery.
    Scherließ R
    Ther Deliv; 2020 Mar; 11(3):183-191. PubMed ID: 32046624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing regional drug delivery within the nasal airways.
    Chen J; Finlay WH; Vehring R; Martin AR
    Expert Opin Drug Deliv; 2024 Apr; 21(4):537-551. PubMed ID: 38568159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal drug delivery--possibilities, problems and solutions.
    Illum L
    J Control Release; 2003 Feb; 87(1-3):187-98. PubMed ID: 12618035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal delivery of systemic-acting drugs: small-molecules and biomacromolecules.
    Fortuna A; Alves G; Serralheiro A; Sousa J; Falcão A
    Eur J Pharm Biopharm; 2014 Sep; 88(1):8-27. PubMed ID: 24681294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic polyacrylate polymers as particulate intranasal vaccine delivery systems for the induction of mucosal immune response.
    Zaman M; Simerska P; Toth I
    Curr Drug Deliv; 2010 Apr; 7(2):118-24. PubMed ID: 20158484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anatomical and histological factors affecting intranasal drug and vaccine delivery.
    Gizurarson S
    Curr Drug Deliv; 2012 Nov; 9(6):566-82. PubMed ID: 22788696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal-nanotechnology: revolution for efficient therapeutics delivery.
    Kumar A; Pandey AN; Jain SK
    Drug Deliv; 2016; 23(3):681-93. PubMed ID: 24901207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical aspects of intranasal delivery of vaccines using particulate systems.
    Sharma S; Mukkur TK; Benson HA; Chen Y
    J Pharm Sci; 2009 Mar; 98(3):812-43. PubMed ID: 18661544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Permeability issues in nasal drug delivery.
    Arora P; Sharma S; Garg S
    Drug Discov Today; 2002 Sep; 7(18):967-75. PubMed ID: 12546871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Application of Mucoadhesive Chitosan Nanoparticles in Nasal Drug Delivery.
    Shim S; Yoo HS
    Mar Drugs; 2020 Nov; 18(12):. PubMed ID: 33260406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.